IncyteCARES Support Program

Helping patients with intermediate or high-risk myelofibrosis who take Jakafi

IncyteCARES (Connecting to Access, Reimbursement, Education and Support) is a support program created by Incyte that assists patients during their treatment with Jakafi, a prescription medicine for people with intermediate or high-risk myelofibrosis. The program not only helps patients gain access to Jakafi, but connects them to ongoing support and resources.

IncyteCARES offers:

  • Prescription insurance verification and prior authorization support
  • Free drug and co-pay assistance, for those who qualify
  • Referral to independent nonprofit organizations or foundations that may be able to provide financial assistance
  • Access to trained nurses

Find out more about IncyteCARES and learn how to enroll your patient.

Join Today

Become a member of Gain access to member-only benefits.


Select and order materials and resources that can assist you and your patients.

Splenomegaly Efficacy

Superior reductions in spleen volume with Jakafi.

Symptoms Efficacy

Superior improvements in core symptoms of myelofibrosis with Jakafi.